Document Detail

Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications.
MedLine Citation:
PMID:  16685019     Owner:  NLM     Status:  MEDLINE    
STUDY OBJECTIVES: Pneumothorax is a common complication of lymphangioleiomyomatosis (LAM), and the optimal approach to its treatment and prevention is unknown. Chemical or surgical pleurodesis are often required to prevent recurrence. However, their efficacy in LAM is unclear, and whether they contribute to perioperative complications during lung transplantation is uncertain.
SETTING: The LAM Foundation database of registered patients.
DESIGN: A questionnaire was sent to all registered patients who had at least one pneumothorax to determine rates and patterns of recurrence and efficacy of interventions. A second questionnaire was sent to registered LAM patients who received a lung transplant.
PATIENTS OR PARTICIPANTS: Of 395 registered patients, 260 patients (66%) reported at least one pneumothorax during their lifetime, 193 of whom (74%) completed the questionnaire. Of the 85 lung transplant patients who were sent a separate questionnaire, 80 patients (94%) responded.
MEASUREMENTS AND RESULTS: Of the 193 respondents to the pneumothorax questionnaire, data on 676 episodes of pneumothorax were collected. Eighty-two percent (158 of 193 patients) had their first pneumothorax prior to a diagnosis of LAM. One hundred forty patients (73%) had at least one additional pneumothorax, either an ipsilateral recurrence (99 of 140 patients, 71%) or a contralateral pneumothorax (104 of 140 patients, 74%). Recurrence rates were 66% after conservative therapy, 27% after chemical pleurodesis, and 32% after surgery. In patients who had undergone lung transplantation, prior chemical or surgical pleurodesis was performed in 45 of 80 patients (56%). Fourteen of 80 patients (18%) reported pleural-related postoperative bleeding, 13 of whom (93%) had prior pleurodesis.
CONCLUSIONS: Chemical pleurodesis or surgery are equally effective and better than conservative therapy in preventing recurrence of pneumothorax in LAM. Due to the high recurrence rate, either procedure should be considered for the initial pneumothorax in these patients. However, both contribute to increased perioperative bleeding following lung transplantation, with no effect on length of hospital stay.
Khalid F Almoosa; Jay H Ryu; Jose Mendez; J Terrill Huggins; Lisa R Young; Eugene J Sullivan; Janet Maurer; Francis X McCormack; Steven A Sahn
Related Documents :
14682599 - Giant bullous lung disease: evaluation, selection, techniques, and outcomes.
19619789 - Thoracoscopic lobectomy is associated with lower morbidity compared with thoracotomy.
10596319 - Video-assisted thoracoscopic pleurodesis for malignant pleural effusions.
19296169 - An apical symphysial technique using a wide absorbable mesh placed on the apex for prim...
17370569 - Ambisome treatment of pulmonary aspergillosis in a patient with tuberculosis.
10192729 - The long-term results of upper dorsal sympathetic ganglionectomy and endoscopic thoraci...
23114239 - Pediatric emergency department census during major sporting events.
11033399 - Fourier analysis of irregular astigmatism after implantation of 3 types of intraocular ...
12427179 - Refusing analgesics: using continuous improvement to improve pain management on a surgi...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Chest     Volume:  129     ISSN:  0012-3692     ISO Abbreviation:  Chest     Publication Date:  2006 May 
Date Detail:
Created Date:  2006-05-10     Completed Date:  2006-05-30     Revised Date:  2014-07-29    
Medline Journal Info:
Nlm Unique ID:  0231335     Medline TA:  Chest     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1274-81     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Follow-Up Studies
Lung Neoplasms / complications,  surgery*
Lung Transplantation*
Lymphangioleiomyomatosis / complications,  surgery*
Middle Aged
Pleurodesis / methods*
Pneumothorax / etiology,  therapy*
Postoperative Complications / prevention & control
Recurrence / prevention & control
Retrospective Studies
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Patient perspectives on management of pneumothorax in lymphangioleiomyomatosis.
Next Document:  Pulmonary embolism as a cause of death in patients with heart disease: an autopsy study.